WKWM
CELG

Walter & Keenan Wealth Management’s Celgene Corp CELG Stock Holding History

Walter & Keenan Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,146
Closed -$818 – 172
2018
Q3 		$818 Hold
9,146
– – 0.24% 71
2018
Q2 		$726K Buy
9,146
+2,500
+38% +$208K 0.31% 75
2018
Q1 		$593K Buy
6,646
+200
+3% +$19.2K 0.26% 83
2017
Q4 		$673K Sell
6,446
-1,608
-20% -$181K 0.28% 76
2017
Q3 		$1.17M Buy
8,054
+254
+3% +$34.6K 0.54% 59
2017
Q2 		$1.01M Buy
+7,800
New +$956K 0.51% 61

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walter & Keenan Wealth Management's CELG Position: Q4 2018 in Review

Walter & Keenan Wealth Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 9,146 shares — an estimated $818 sold.

Walter & Keenan Wealth Management first reported a position in CELG in Q2 2017 and held it in 6 quarters. The position peaked at $1.17M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Walter & Keenan Wealth Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Walter & Keenan Wealth Management sold 9,146 Celgene Corp shares in Q4 2018, an estimated $818.
  • Walter & Keenan Wealth Management first reported a position in Celgene Corp in Q2 2017 and held it in 6 quarters.
  • Walter & Keenan Wealth Management's Celgene Corp position peaked at $1.17M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Walter & Keenan Wealth Management's 13F filing for Q4 2018, filed 1 Feb 2019.